| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |